Mitomycin-C Induced Hemolytic Uremic Syndrome: A Case Report and Literature Review

Japanese Journal of Clinical Oncology

Volumn 27, Issue 2, 1997, Pages 115-118

  Wu, Dou Chen ^a   Liu, Jacqueline Ming ^a,b   Chen, Yuh Min ^a   Yang, Shuling ^b   Liu, Shian Min ^a   Chen, Li Tzong ^b   Whang Peng, Jacqueline ^b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Hemolytic uremic syndrome; Mitomycin C; Staphylococcal A column dialysis

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; MITOMYCIN;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; CASE REPORT; CHEMICALLY INDUCED DISORDER; DRUG ADMINISTRATION; FEMALE; GASTRECTOMY; HEMOLYTIC UREMIC SYNDROME; HUMAN; MIDDLE AGED; REVIEW; STOMACH TUMOR;

ADENOCARCINOMA; ANTIBIOTICS, ANTINEOPLASTIC; CHEMOTHERAPY, ADJUVANT; DRUG ADMINISTRATION SCHEDULE; FEMALE; GASTRECTOMY; HEMOLYTIC-UREMIC SYNDROME; HUMANS; MIDDLE AGED; MITOMYCIN; STOMACH NEOPLASMS;

EID: 0031113953     PISSN: 03682811     EISSN: None     Source Type: Journal    
DOI: 10.1093/jjco/27.2.115     Document Type: Article

References (27)

1. Moake JL. Hemolytic uremic syndrome: basic science and in practice. Lancet 1994;343:393-403
2. Gradishar WJ, Yokes EE, Ni K, Panje WR. Chemotherapy-related hemolytic uremic syndrome after the treatment of head and neck cancer: a case report. Cancer 1990;06:1914-18
3. Hanna WT, Krauss S, Regester RF, Murphy WM. Renal disease after mitomycin C therapy. Cancer 1981;48:2583-8
4. Liu K, Mittelman A, Sproul EE, Elias EG. Renal toxicity in a man treated with mitomycin C. Cancer 1981;28:1314-20.
5. Valavaara R Nordman E. Renal complications of mitomycin C therapy with special reference to the total dose. Cancer 1985;35:47-50.
6. Price TM, Murgo AJ, Keveny JJ, Miller-Hardy D, Kasprisin DO. Renal failure and hemolytic anemia associated with mitomycin C a case report. Cancer 1985;55:51-6.
7. Onega Marcos O, Escuin F, Miguel JL, Gomez Fernandez P, Perez Fontan M, Selgas R et al Hemolytic uremic syndrome in a patient with gastric adenocarcinoma: partial recovery of renal function after gastrectomy. Clinical Nephrology 1985;24:265-8
8. Ruggenenti P Remuzzi G. Thrombotic thrombocytopenic purpura and related disorders Hematol/Oncol Clin North Am 1990;4:239-41
9. Cattell V Mitomycin induced hemolytic uremic kidney: an experimental model in the rat. Amer J Path 1985;121:88-95.
10. Olavarria F, Mezzano S, Valderrama G. Detection of antineutrophil cytoplasmic antibodies in the classic form of hemolytic uremic syndrome. Nephron 1994;66-235
11. Olavarria F, Pereira J, Mezzano S, Kunick M, Castillo A. A study on the antigenic nature of circulating immune complexes in hemolytic uremic syndrome: no evidence of platelet membrane glycoprotein antigens. Nephron 1994;66:58-61.
12. Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B. A reported transgene indicates renal specific induction of tumour necrosis factor (TNF) by shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest 1993;92:2110-6.
13. Lucca LJ, Ressurreicao FA, Ferraz AS, Costa RS, Costa JA, Pisi TM et al. De novo hemolytic uremic syndrome: a rare adverse effect in renal transplant recipients immunosuppressed with cyclosporine. Transplantation Proceedings 1992;24:3098-9.
14. Verwey J, Boven E, van der Meulen J, Pinedo HM. Recovery from mitomycin C induced hemolytic uremic syndrome: a case report. Cancer 1984;54:2878-81.
15. Cantrell JE Jr, Philips TM, Schein PS. Carcinoma associated hemolytic uremic syndrome: a complication of mitomycin C chemotherapy. J Clin Oncol 1985;3:723-34
16. Khansur T, Kennedy A. Case report: cisplatin induced hemolytic uremic syndrome. Am J Med Sci 1991;301:390-2.
17. Doll DC, Weiss RB. Hemolytic anemia associated with antineoplastic agents Can Treat Rep 1985;69:777-82.
18. Chow S, Roscoe J, Cattran DC. Plasmapheresis and antiplatelet agents in the treatment of the hemolytic uremic syndrome secondary to mitomycin. Am J Kid Dis 1986;7:407-12.
19. Garibotto G, Acquarone N, Saffioti S, Deferrari G, Villaggio B, Ferrario F. Successful treatment of mitomycin C associated hemolytic uremic syndrome by plasmapheresis. Nephron 1989;51:409-12,
20. Poch E, Almirall J, Nicolas JM, Torras A, Revert L. Treatment of mitomycin C associated hemolytic uremic syndrome with plasmapheresis. Nephron 1990;55:89-90.
21. Snyder HW Jr, Mittelman A, Oral A, Messerschmidt GL, Henry DH, Korec S et al. Treatment of cancer chemotherapy associated thrombotic thrombocytopenic purpura/hemolytic uremic syndrome by protein A immunoadsorption of plasma. Cancer 1993;71:1882-92.
22. Watson PR, Guthrie TH Jr, Caruana RJ. Cisplatin associated hemolytic uremic syndrome by protein A immunoadsorption of plasma. Successful treatment with a staphyloccocal protein A column. Cancer 1989;64:1400-3.
23. Jolivet J, Giroux L, Laurin S, Gruber J, Bettez P, Band PR. Microangiopathic hemolytic anemia, renal failure, and non-cardiogenic pulmonary edema: a chemotherapy induced syndrome. Can Treat Rep 1983;67:429-34.
24. Korec S, Schein PS, Smith FP, Neefe JR, Woolley PV, Goldberg RM et al. Treatment of cancer associated hemolytic uremic syndrome with staphylococcal protein A immunoperfusion J Clin Oncol 1986;4:210-5.
25. Lesesne JB, Rothschild N, Erickson B, Korec S, Sisk R, Keller J et al. Cancer-associated hemolytic uremic syndrome: analysis of 85 cases from a national registry. J Clin Oncol 1989;7:781-9.
26. Verwey J, de Vries J, Pinedo HM. Mitomycin-C induced renal toxicity, a dose dependent side effect? Eur J Cancer Clin Oncol 1987;23:195-9.
27. Kambhu SA, Kelsen DP, Fiore J, Niedzwiecki D, Chapman D, Vinciguerra V et al. Metastatic adenocarcinoma of unknown primary site: prognostic variables and treatment results. Am J Clin Oncol 1990;13:55-60